rewirebio.iobenchmarks
Configuration

BayesDel generic Pejaver evidence thresholds in ENIGMA comparison

Generic BP4 supporting threshold ≤−0.18 and PP3 supporting threshold ≥0.13, applied to BRCA functional benign reference sets. These are evidence codes, not full pathogenicity classifications.

2 evaluations · 4 results6 open disagreements between studies involve its model

Overview

An explanatory profile has not yet been reviewed for this record.

Consult the linked sources for architecture or protocol details. Missing evidence is not evidence of a missing capability.

Model Capabilities & Hardware Requirements

Deployment facts recorded for BayesDel generic Pejaver evidence thresholds in ENIGMA comparison. Fields the record does not carry are marked not recorded.

ParametersNot recorded
Minimum VRAMNot recorded
Inference LatencyNot recorded
Context WindowNot recorded
AccessNot recorded
LicenseNot recorded

Evaluations and results

2 evaluations · 4 results. Different protocols are not a single leaderboard.

Sorted by Proportion (benign reference variants assigned BP4) (higher is better). The best value in each column is highlighted. Decimals are rounded for display; each value links to the printed value and its source.

All 4 result rows with coverage, uncertainty and sources
Filter evaluations

Applied filters: All linked evaluations

Exact evaluated configurations and original reported results
Tested configurationProtocol and datasetFindingEvidence and details
Configuration: BayesDel generic Pejaver evidence thresholds in ENIGMA comparisonProtocol: BRCA1 generic BayesDel threshold evidence-code assignment
Dataset: BRCA1 functional reference calibration set
<10% Proportion (benign reference variants assigned BP4)
percent · higher

Uncertainty: Not reported by the source: not reported for this endpoint

Coverage: Not reported scored / Not reported eligible

Author-reported evaluation · Source checked
Methods, coverage and source

BRCA1 generic BayesDel threshold comparator

Not reported

Aggregation: Not reported

Evidence-based recommendations for gene-specific ACMG/AMP variant classification from the ClinGen ENIGMA BRCA1 and BRCA2 Variant Curation Expert Panel · Results, BayesDel calibration, BP4 code would be assigned to <10% of BRCA1 and BRCA2 benign reference variants
Configuration: BayesDel generic Pejaver evidence thresholds in ENIGMA comparisonProtocol: BRCA1 generic BayesDel threshold evidence-code assignment
Dataset: BRCA1 functional reference calibration set
29% Proportion (benign reference variants assigned PP3)
percent · lower

Uncertainty: Not reported by the source: not reported for this endpoint

Coverage: Not reported scored / Not reported eligible

Author-reported evaluation · Source checked
Methods, coverage and source

BRCA1 generic BayesDel threshold comparator

Not reported

Aggregation: Not reported

Evidence-based recommendations for gene-specific ACMG/AMP variant classification from the ClinGen ENIGMA BRCA1 and BRCA2 Variant Curation Expert Panel · Results, BayesDel calibration, sentence 29% for BRCA1 and 36% for BRCA2 incorrectly assigned PP3
Configuration: BayesDel generic Pejaver evidence thresholds in ENIGMA comparisonProtocol: BRCA2 generic BayesDel threshold evidence-code assignment
Dataset: BRCA2 functional reference calibration set
<10% Proportion (benign reference variants assigned BP4)
percent · higher

Uncertainty: Not reported by the source: not reported for this endpoint

Coverage: Not reported scored / Not reported eligible

Author-reported evaluation · Source checked
Methods, coverage and source

BRCA2 generic BayesDel threshold comparator

Not reported

Aggregation: Not reported

Evidence-based recommendations for gene-specific ACMG/AMP variant classification from the ClinGen ENIGMA BRCA1 and BRCA2 Variant Curation Expert Panel · Results, BayesDel calibration, BP4 code would be assigned to <10% of BRCA1 and BRCA2 benign reference variants
Configuration: BayesDel generic Pejaver evidence thresholds in ENIGMA comparisonProtocol: BRCA2 generic BayesDel threshold evidence-code assignment
Dataset: BRCA2 functional reference calibration set
36% Proportion (benign reference variants assigned PP3)
percent · lower

Uncertainty: Not reported by the source: not reported for this endpoint

Coverage: Not reported scored / Not reported eligible

Author-reported evaluation · Source checked
Methods, coverage and source

BRCA2 generic BayesDel threshold comparator

Not reported

Aggregation: Not reported

Evidence-based recommendations for gene-specific ACMG/AMP variant classification from the ClinGen ENIGMA BRCA1 and BRCA2 Variant Curation Expert Panel · Results, BayesDel calibration, sentence 29% for BRCA1 and 36% for BRCA2 incorrectly assigned PP3

Source checking is not independent reproduction. Release 2026-11-21-adc15377fab2.

Use this configuration

How it works, versions and access

Related profile: BayesDel. This page retains the exact record and its evaluation context.

Evidence

Source checking verifies the cited claim or transcription. It does not establish independent reproduction.

Evidence table

Inspect claims, sources and review details

Trace each statement to its source and review. A context-only reference supports the record generally; it does not verify an individual field. Source checking does not reproduce an experiment.

One row per statement and cited source. Multiple citations are not independent evaluations. Shared locators are labelled explicitly.

3 evidence rows matching the loaded filters

Claims, original sources and review scope · Release 2026-11-21-adc15377fab2
Property and statementOriginal source and locationReview and provenance
Facets: method types
1 values
  • supervised_machine_learning
Individual claims
ACMG/AMP interpretation of BRCA1 missense variants: Structure-informed scores add evidence strength granularity to the PP3/BP4 computational evidence

Original source ↗

Matches the other 7 BayesDel configurations; Ramadane 2025 calls BayesDel a meta-predictor

Shared locator for this statement’s cited sources; not a separate locator for each citation.

Version: American Journal of Human Genetics 112(5):993, published 2025; PMC12120176 full-text XML
Retrieved: 2026-10-09T21:18:06Z

conflicting claim

["source-hash-verification","automated-source-review"] · 2026-10-12

Audit details

Correct the method type from none to supervised_machine_learning (use-case baseline review 2026-10-12, table 2). Evidence from docs/reviews/use-cases/baselines-2026-10-12.md. Independent review 2026-10-12: approved. See docs/reviews/2026-10-12-method-type-corrections.md.

Conflicting source claim: "[\"supervised_machine_learning\"]". Claim record status: source_checked.

Field: facets.method_types

Claim: metadata-correction-tags-20261012-8aa780483a6028222493

Source artifact SHA-256: cd089e7c621818f457f54f93c37cc1b9d535e531212b1aaf431fcbdd733bbda1

Hash scope: Hash scope not separately documented; inspect source record

Inspected artifact

Extraction artifact SHA-256: cd089e7c621818f457f54f93c37cc1b9d535e531212b1aaf431fcbdd733bbda1

Extraction artifact

Facets: method types
1 values
  • supervised_machine_learning
Individual claims
Evidence-based recommendations for gene-specific ACMG/AMP variant classification from the ClinGen ENIGMA BRCA1 and BRCA2 Variant Curation Expert Panel

Original source ↗

Matches the other 7 BayesDel configurations; Ramadane 2025 calls BayesDel a meta-predictor

Shared locator for this statement’s cited sources; not a separate locator for each citation.

Version: 2024 final article; reported VCEP specifications v1.0
Retrieved: 2026-09-30T21:24:15Z

conflicting claim

["source-hash-verification","automated-source-review"] · 2026-10-12

Audit details

Correct the method type from none to supervised_machine_learning (use-case baseline review 2026-10-12, table 2). Evidence from docs/reviews/use-cases/baselines-2026-10-12.md. Independent review 2026-10-12: approved. See docs/reviews/2026-10-12-method-type-corrections.md.

Conflicting source claim: "[\"supervised_machine_learning\"]". Claim record status: source_checked.

Field: facets.method_types

Claim: metadata-correction-tags-20261012-8aa780483a6028222493

Source artifact SHA-256: 21e7b0792e18a1295b7bccb8b19ebe4432a2b047187139407c8616ea0cd531f2

Hash scope: Hash scope not separately documented; inspect source record

Inspected artifact

Extraction artifact SHA-256: cd089e7c621818f457f54f93c37cc1b9d535e531212b1aaf431fcbdd733bbda1

Extraction artifact

Relationship: configuration of
uc-clinical-20260930-method-bayesdel
Individual claims
Evidence-based recommendations for gene-specific ACMG/AMP variant classification from the ClinGen ENIGMA BRCA1 and BRCA2 Variant Curation Expert Panel

Original source ↗

Results; Table 2; reference 22

Version: 2024 final article; reported VCEP specifications v1.0
Retrieved: 2026-09-30T21:24:15Z

source checked

["automated-source-review"] · 2026-09-30

Audit details

Transcription from inspected primary source. No execution, independent replication or human scientific review.

Field: links:configuration_of:uc-clinical-20260930-method-bayesdel

Claim: uc-clinical-20260930-association-bayesdel-pejaver-generic

Source artifact SHA-256: 21e7b0792e18a1295b7bccb8b19ebe4432a2b047187139407c8616ea0cd531f2

Hash scope: Hash scope not separately documented; inspect source record

Inspected artifact

Sources and history

Release 2026-11-21-adc15377fab2 · Record review: source checked

1 source record and release historyDownload this release (gzip)
Technical metadata and record identifiers

Technical metadata for this record is tracked under stable ID uc-clinical-20260930-bayesdel-pejaver-generic.

Related records

How to cite

BayesDel generic Pejaver evidence thresholds in ENIGMA comparison. Rewire biological model benchmark database, release 2026-11-21-adc15377fab2. https://benchmarks.rewirebio.io/database/configuration/uc-clinical-20260930-bayesdel-pejaver-generic/

Release 2026-11-21-adc15377fab2. Rankings and values change between releases, so keep the release id in the citation. Cite the original publication as well for any value you reuse: each result links its source.

The compilation and annotations made by Rewire in this release are offered under CC BY 4.0; values and text taken from cited sources stay under the terms of those sources and are not covered by this licence. Data licence

Suggest a correction